TGFB1 and neoplasm: Blockade of TGF-β skews mouse neutrophils differentiation to an anti-tumorigenic phenotype (N1), with more cytokine and chemokine production, lower levels of arginase and a stronger ability to kill tumor cells in vitro [32].